Australian owned & operatedAustralian flag
Card Payments AvailableVisaMastercardApple Pay
Home/Shop/Retatrutide 30mg
Retatrutide 30mg lyophilised powder vial – Solatide Biosciences research peptide, not for human consumption

Images are for illustration purpose only

Retatrutide 30mg

★★★★★
14 Reviews

Research Use Only: This product is strictly for laboratory research and is not intended for human or veterinary consumption, therapeutic use, diagnostic use, or clinical application.

Useful Resources: Concentration Calculator | Retatrutide Research Overview | What Is Retatrutide? | GLP-1 Research Overview | COA & Lab Testing


Current Batch
SB26X7A2-RET30Now Shipping

This batch has third party test results

4 Tests Available
Test Summary
Purity

Purity

99.52%

HPLC

Pass

Identity

Identity

Confirmed

LC-MS

Pass

Net Peptide Content

Net Peptide Content

30.82 mg

Pass

Fentanyl Screen

Fentanyl Screen

Not Detected

Safety screen

Pass

Verified by ILS Laboratories|ISO/IEC 17025 Accredited

Official COA Verification

Independent Lab Verification

Scan the QR code to verify this certificate directly on the ILS Laboratories secure portal.

Access Code
LH3V6JER
$259.99 AUD
Quantity
1

Product Overview

Understanding Retatrutide 30mg

Retatrutide 30mg is a triple agonist peptide targeting GLP-1, GIP, and Glucagon receptors, supplied as a single high-volume lyophilised analytical reference material for in-vitro laboratory and analytical use. The 30mg format is suited to extended laboratory study programmes requiring larger reconstitution volumes or multiple experimental runs. Products selected for website presentation meet Solatide Biosciences' ≥99% purity standard based on available third-party documentation.

Research Applications

•Triple GLP-1/GIP/Glucagon Receptor Binding Studies: Investigate simultaneous multi-receptor binding kinetics and downstream pathway activation in experimental models.
•High-Volume Multi-Pathway Research: Conduct extended incretin signalling studies across multiple experimental runs from a single high-volume vial.
•Comparative Triple vs Dual Agonist Studies: Compare Retatrutide triple agonism against Tirzepatide dual agonism in receptor pharmacology assays.
•Metabolic Signalling Pathway Investigations: Examine multi-receptor metabolic signalling consequences and downstream effector pathway analysis in vitro.
This analytical standard is strictly for in-vitro laboratory research use only.

Technical Specifications

Technical Parameter
Laboratory Specification
Purity
99.52% by HPLC, ILS Laboratories, lot SB26X7A2-RET30
Molecular formula
C₂₄₄H₃₉₄N₆₈O₇₂
Molecular weight
5765.50 g/mol
CAS number
2381089-83-2
Appearance
White lyophilised powder
Storage
Short term: 2–8°C. Long term: −20°C. Keep unopened material sealed, dry and protected from light.

Batch-specific third-party documentation available. Reports may include testing from independent laboratories such as Janoshik, Chromate, and Freedom Diagnostics, depending on the batch. View our COA & Lab Testing page for details.

Reviews

Customer Reviews

5.0
★★★★★
Based on 14 verified reviews
E
Erin
28/09/2026

Exactly as listed

No surprises when it arrived, which is exactly what I want.

R
Rubin
26/09/2026

Made my day!

Parcel arrived and I was so excited haha. Thanks team!!!

A
Anon
23/09/2026

A cautious buyer's take

I don't rush purchases like this. I read through the available reports, checked the business details and sent a question before proceeding. The response was very thorough, the reports ar elegit and paying by card meant I was comfortable completing the order.

H
Hannah L
20/09/2026

Legit

legit place. Defintiely order from here

J
Jay M
14/09/2026

The testing sold me

I was comparing the actual reports rather than just reading marketing claims. Having batch information available made the decision for me. Checkout was familiar and the rest of the process ran exactly as it should.

Cart

0

Your cart is currently empty.